{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:43:48Z","timestamp":1787697828138,"version":"build-2784847793"},"reference-count":267,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Pancreatic ductal adenocarcinoma (PDAC) is one of the most fatal types of solid tumors, associated with a high prevalence of cachexia (~80%). PDAC-derived cachexia (PDAC-CC) is a systemic disease involving the complex interplay between the tumor and multiple organs. The endocrine organ\u2013like tumor (EOLT) hypothesis may explain the systemic crosstalk underlying the deleterious homeostatic shifts that occur in PDAC-CC. Several studies have reported a markedly heterogeneous collection of cachectic mediators, signaling mechanisms, and metabolic pathways, including exocrine pancreatic insufficiency, hormonal disturbance, pro-inflammatory cytokine storm, digestive and tumor-derived factors, and PDAC progression. The complexities of PDAC-CC necessitate a careful review of recent literature summarizing cachectic mediators, corresponding metabolic functions, and the collateral impacts on wasting organs. The EOLT hypothesis suggests that metabolites, genetic instability, and epigenetic changes (microRNAs) are involved in cachexia development. Both tumors and host tissues can secrete multiple cachectic factors (beyond only inflammatory mediators). Some regulatory molecules, metabolites, and microRNAs are tissue-specific, resulting in insufficient energy production to support tumor\/cachexia development. Due to these complexities, changes in a single factor can trigger bi-directional feedback circuits that exacerbate PDAC and result in the development of irreversible cachexia. We provide an integrated review based on 267 papers and 20 clinical trials from PubMed and ClinicalTrials.gov database proposed under the EOLT hypothesis that may provide a fundamental understanding of cachexia development and response to current treatments.<\/jats:p>","DOI":"10.3389\/fonc.2022.1057930","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T06:22:36Z","timestamp":1668666156000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Review of the endocrine organ\u2013like tumor hypothesis of cancer cachexia in pancreatic ductal adenocarcinoma"],"prefix":"10.3389","volume":"12","author":[{"given":"Ying-Chun","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azaj","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsueh-Chou","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chung","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Chern","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Shen","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Lung","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the united states","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14740\/wjon1166","article-title":"Epidemiology of pancreatic cancer: Global trends, etiology and risk factors","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.3390\/cancers14112588","article-title":"Systemic therapy of metastatic pancreatic adenocarcinoma: Current status, challenges, and opportunities","volume":"14","author":"Chakrabarti","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-020-05346-8","article-title":"Incidence and frequency of cancer cachexia during chemotherapy for advanced pancreatic ductal adenocarcinoma","volume":"28","author":"Mitsunaga","year":"2020","journal-title":"Supportive Care Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.21037\/jgo.2017.11.10","article-title":"Cachexia, and not obesity, prior to pancreatic cancer diagnosis worsens survival and is negated by chemotherapy","volume":"9","author":"Hendifar","year":"2018","journal-title":"J Gastrointest Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1634\/theoncologist.2018-0266","article-title":"Pancreas cancer-associated weight loss","volume":"24","author":"Hendifar","year":"2019","journal-title":"oncologist"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-008-0505-z","article-title":"Cachexia worsens prognosis in patients with resectable pancreatic cancer","volume":"12","author":"Bachmann","year":"2008","journal-title":"J gastrointestinal Surg Off J Soc Surg Alimentary Tract"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-021-01301-4","article-title":"Pancreatic cancer cachexia: Three dimensions of a complex syndrome","volume":"124","author":"Kordes","year":"2021","journal-title":"Br J Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.3390\/nu12061543","article-title":"Pancreatic cancer and cachexia-metabolic mechanisms and novel insights","volume":"12","author":"Poulia","year":"2020","journal-title":"Nutrients"},{"key":"B10","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3390\/cancers11050709","article-title":"Continued weight loss and sarcopenia predict poor outcomes in locally advanced pancreatic cancer treated with chemoradiation","volume":"11","author":"Naumann","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188359","article-title":"Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions","volume":"1873","author":"Siddiqui","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2013.804580","article-title":"Cachexia in patients with chronic pancreatitis and pancreatic cancer: Impact on survival and outcome","volume":"65","author":"Bachmann","year":"2013","journal-title":"Nutr Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-255","article-title":"Pancreatic cancer related cachexia: Influence on metabolism and correlation to weight loss and pulmonary function","volume":"9","author":"Bachmann","year":"2009","journal-title":"BMC Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2012.05.028","article-title":"Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer","volume":"152","author":"Pausch","year":"2012","journal-title":"Surgery"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.3390\/ijms22062890","article-title":"Cachexia as evidence of the mechanisms of resistance and tolerance during the evolution of cancer disease","volume":"22","author":"Maccio","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"8592","DOI":"10.3390\/ijms21228592","article-title":"Cachexia, a systemic disease beyond muscle atrophy","volume":"21","author":"Wyart","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1038\/s41598-022-05660-7","article-title":"Visceral adipose tissue remodeling in pancreatic ductal adenocarcinoma cachexia: The role of activin a signaling","volume":"12","author":"Xu","year":"2022","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.01.039","article-title":"Phases of metabolic and soft tissue changes in months preceding a diagnosis of pancreatic ductal adenocarcinoma","volume":"156","author":"Sah","year":"2019","journal-title":"Gastroenterology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00033","article-title":"Fat wasting is damaging: Role of adipose tissue in cancer-associated cachexia","volume":"8","author":"Sun","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190450","article-title":"Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia","volume":"218","author":"Rupert","year":"2021","journal-title":"J Exp Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-021-00582-2","article-title":"Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor","volume":"53","author":"Yoo","year":"2021","journal-title":"Exp Mol Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0235-7","article-title":"Altered exocrine function can drive adipose wasting in early pancreatic cancer","volume":"558","author":"Danai","year":"2018","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.3390\/cells11101607","article-title":"Inflammation and wasting of skeletal muscles in Kras-p53-Mutant mice with intraepithelial neoplasia and pancreatic cancer-when does cachexia start","volume":"11","author":"Hildebrandt","year":"2022","journal-title":"Cells"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199404000-00001","article-title":"Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer","volume":"219","author":"Falconer","year":"1994","journal-title":"Ann Surg"},{"key":"B26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s12032-016-0768-2","article-title":"Alterations in inflammatory biomarkers and energy intake in cancer cachexia: A prospective study in patients with inoperable pancreatic cancer","volume":"33","author":"Bye","year":"2016","journal-title":"Med Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.1997.02525.x","article-title":"Contribution of anorexia and hypermetabolism to weight loss in anicteric patients with pancreatic cancer","volume":"84","author":"Wigmore","year":"1997","journal-title":"Br J Surg"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.advms.2013.11.001","article-title":"Anorexia-cachexia syndrome in pancreatic cancer: Recent advances and new pharmacological approach","volume":"59","author":"Ronga","year":"2014","journal-title":"Adv Med Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: Mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab"},{"key":"B30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","article-title":"The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation","volume":"7","author":"DeBerardinis","year":"2008","journal-title":"Cell Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12794","article-title":"Hypothesis: Solid tumours behave as systemic metabolic dictators","volume":"20","author":"Lee","year":"2016","journal-title":"J Cell Mol Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41574-018-0123-0","article-title":"Inter-tissue communication in cancer cachexia","volume":"15","author":"Argil\u00e9s","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1210\/er.2010-0030","article-title":"Paracrine and endocrine effects of adipose tissue on cancer development and progression","volume":"32","author":"Park","year":"2011","journal-title":"Endocr Rev"},{"key":"B34","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1053\/j.gastro.2018.10.026","article-title":"Zip4 promotes muscle wasting and cachexia in mice with orthotopic pancreatic tumors by stimulating Rab27b-regulated release of extracellular vesicles from cancer cells","volume":"156","author":"Yang","year":"2019","journal-title":"Gastroenterology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(03)15268-3","article-title":"WHO Expert Consultation Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","year":"2004","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1177\/0148607108325076","article-title":"Defining and classifying cancer cachexia: A proposal by the scrinio working group","volume":"33","author":"Bozzetti","year":"2009","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/83.6.1345","article-title":"Definition of cancer cachexia: Effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis","volume":"83","author":"Fearon","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2013.11.007","article-title":"Towards a simple objective framework for the investigation and treatment of cancer cachexia: The Glasgow prognostic score","volume":"40","author":"Douglas","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"B40","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s13539-011-0027-5","article-title":"The cachexia score (Casco): A new tool for staging cachectic cancer patients","volume":"2","author":"Argil\u00e9s","year":"2011","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: A new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr (Edinburgh Scotland)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12275","article-title":"Development and validation of a clinically applicable score to classify cachexia stages in advanced cancer patients","volume":"9","author":"Zhou","year":"2018","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B43","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4137\/cmo.S30891","article-title":"Cachexia index in advanced non-Small-Cell lung cancer patients","volume":"9","author":"Jafri","year":"2015","journal-title":"Clin Med Insights Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"7647","DOI":"10.1038\/s41598-022-11736-1","article-title":"Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy","volume":"12","author":"Goh","year":"2022","journal-title":"Sci Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12756","article-title":"Diagnostic criteria for cancer cachexia: Reduced food intake and inflammation predict weight loss and survival in an international, multi-cohort analysis","volume":"12","author":"Martin","year":"2021","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/0899-9007(96)90011-8","article-title":"Definition of standardized nutritional assessment and interventional pathways in oncology","volume":"12","author":"Ottery","year":"1996","journal-title":"Nutr (Burbank Los Angeles County Calif)"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2016.09.010","article-title":"Development of the eortc qlq-Cax24, a questionnaire for cancer patients with cachexia","volume":"53","author":"Wheelwright","year":"2017","journal-title":"J Pain Symptom Manage"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2011.05.009","article-title":"Mini nutritional assessment (Mna) and biochemical markers of cachexia in metastatic lung cancer patients: Interrelations and associations with prognosis","volume":"74","author":"Gioulbasanis","year":"2011","journal-title":"Lung Cancer"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-015-2606-z","article-title":"Validation and real-world assessment of the functional assessment of anorexia-cachexia therapy (Faact) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (Cacs)","volume":"23","author":"LeBlanc","year":"2015","journal-title":"Supportive Care Cancer"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6606087","article-title":"An inflammation-based prognostic score (Mgps) predicts cancer survival independent of tumour site: A Glasgow inflammation outcome study","volume":"104","author":"Proctor","year":"2011","journal-title":"Br J Cancer"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2014.56.1894","article-title":"Diagnostic criteria for the classification of cancer-associated weight loss","volume":"33","author":"Martin","year":"2015","journal-title":"J Clin Oncol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12200","article-title":"The influence of different muscle mass measurements on the diagnosis of cancer cachexia","volume":"8","author":"Blauwhoff-Buskermolen","year":"2017","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B53","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3390\/nu12030755","article-title":"Reference values for skeletal muscle mass - current concepts and methodological considerations","volume":"12","author":"Walowski","year":"2020","journal-title":"Nutrients"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12831","article-title":"Computed tomography-defined low skeletal muscle index and density in cancer patients: Observations from a systematic review","volume":"12","author":"McGovern","year":"2021","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B55","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0899-9007(95)00017-8","article-title":"Dual-energy X-ray absorptiometry and body composition","volume":"12","author":"Laskey","year":"1996","journal-title":"Nutr (Burbank Los Angeles County Calif)"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2013.07.015","article-title":"Clinical evaluation and optimal management of cancer cachexia","volume":"88","author":"Tuca","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2008.12.009","article-title":"Evaluating cognitive, emotional, and physical fatigue domains in daily practice by single-item questions in patients with advanced cancer: A cross-sectional pragmatic study","volume":"38","author":"Strasser","year":"2009","journal-title":"J Pain Symptom Manage"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-002-0390-z","article-title":"Assessment of nutritional status and prognosis in advanced cancer: Interleukin-6, c-reactive protein, and the prognostic and inflammatory nutritional index","volume":"11","author":"Walsh","year":"2003","journal-title":"Support Care Cancer"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(80)90246-9","article-title":"Prognostic nutritional index in gastrointestinal surgery","volume":"139","author":"Buzby","year":"1980","journal-title":"Am J Surg"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2016.96","article-title":"Key determinants of energy expenditure in cancer and implications for clinical practice","volume":"70","author":"Purcell","year":"2016","journal-title":"Eur J Clin Nutr"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6214838","article-title":"Glucose and lactate transport in pancreatic cancer: Glycolytic metabolism revisited","volume":"2018","author":"Cameron","year":"2018","journal-title":"J Oncol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12943-020-01169-7","article-title":"Metabolism of pancreatic cancer: Paving the way to better anticancer strategies","volume":"19","author":"Qin","year":"2020","journal-title":"Mol Cancer"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1219555110","article-title":"Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma","volume":"110","author":"Guillaumond","year":"2013","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.01.058","article-title":"Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism","volume":"149","author":"Ying","year":"2012","journal-title":"Cell"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.11.025","article-title":"MCT4 defines a glycolytic subtype of pancreatic cancer with poor prognosis and unique metabolic dependencies","volume":"9","author":"Baek","year":"2014","journal-title":"Cell Rep"},{"key":"B66","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12885-018-4271-3","article-title":"The warburg effect in human pancreatic cancer cells triggers cachexia in athymic mice carrying the cancer cells","volume":"18","author":"Wang","year":"2018","journal-title":"BMC Cancer"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3892\/or_00000328","article-title":"Pro-inflammatory cytokine release by peripheral blood mononuclear cells from patients with advanced pancreatic cancer: Relationship to acute phase response and survival","volume":"21","author":"Moses","year":"2009","journal-title":"Oncol Rep"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-05-0185","article-title":"Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia","volume":"11","author":"Martignoni","year":"2005","journal-title":"Clin Cancer Res an Off J Am Assoc Cancer Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.54095","article-title":"Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer","volume":"9","author":"Burfeind","year":"2020","journal-title":"Elife"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(87)90028-6","article-title":"Tumors secreting human TNF\/Cachectin induce cachexia in mice","volume":"50","author":"Oliff","year":"1987","journal-title":"Cell"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1038\/s41467-021-22361-3","article-title":"Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia","volume":"12","author":"Olson","year":"2021","journal-title":"Nat Commun"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12528","article-title":"Cancer cachexia and its pathophysiology: Links with sarcopenia, anorexia and asthenia","volume":"11","author":"Peixoto da Silva","year":"2020","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.15.4.823","article-title":"Peripheral blood cells from weight-losing cancer patients control the hepatic acute phase response by a primarily interleukin-6 dependent mechanism","volume":"15","author":"O'Riordain","year":"1999","journal-title":"Int J Oncol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12804","article-title":"Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients","volume":"12","author":"Ubachs","year":"2021","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12251","article-title":"Circulating monocyte chemoattractant protein-1 (Mcp-1) is associated with cachexia in treatment-na\u00efve pancreatic cancer patients","volume":"9","author":"Talbert","year":"2018","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.4129","article-title":"Fecal microbiome composition in pancreatic cancer cachexia and response to nutrition support","volume":"39","author":"Moshayedi","year":"2021","journal-title":"J Clin Oncol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319807","article-title":"Therapeutic potential of microbial modulation in pancreatic cancer","volume":"70","author":"Chandra","year":"2021","journal-title":"Gut"},{"key":"B78","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12943-019-1008-0","article-title":"The microbiota and microbiome in pancreatic cancer: More influential than expected","volume":"18","author":"Wei","year":"2019","journal-title":"Mol Cancer"},{"key":"B79","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","article-title":"Tumor microbiome diversity and composition influence pancreatic cancer outcomes","volume":"178","author":"Riquelme","year":"2019","journal-title":"Cell"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3892\/or_00000231","article-title":"Liver macrophages contribute to pancreatic cancer-related cachexia","volume":"21","author":"Martignoni","year":"2009","journal-title":"Oncol Rep"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7120502","article-title":"Elevated serum interleukin-8 level correlates with cancer-related cachexia and sarcopenia: An indicator for pancreatic cancer outcomes","volume":"7","author":"Hou","year":"2018","journal-title":"J Clin Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.3390\/cancers11101460","article-title":"Glucose metabolism in pancreatic cancer","volume":"11","author":"Yan","year":"2019","journal-title":"Cancers"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/nature12040","article-title":"Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway","volume":"496","author":"Son","year":"2013","journal-title":"Nature"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1097\/mpa.0000000000000571","article-title":"Monocarboxylate transporters MCT1 and MCT4 regulate migration and invasion of pancreatic ductal adenocarcinoma cells","volume":"45","author":"Kong","year":"2016","journal-title":"Pancreas"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.3652","article-title":"Distinct glycolytic pathway regulation in liver, tumour and skeletal muscle of mice with cancer cachexia","volume":"39","author":"Visavadiya","year":"2021","journal-title":"Cell Biochem Funct"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154169","article-title":"Cancer causes metabolic perturbations associated with reduced insulin-stimulated glucose uptake in peripheral tissues and impaired muscle microvascular perfusion","volume":"105","author":"Han","year":"2020","journal-title":"Metabolism"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115153","article-title":"Metabolic phenotypes in pancreatic cancer","volume":"10","author":"Yu","year":"2015","journal-title":"PloS One"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00088","article-title":"Pancreatic cancer cachexia: A review of mechanisms and therapeutics","volume":"5","author":"Tan","year":"2014","journal-title":"Front Physiol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2019.05.029","article-title":"Autophagy and mitophagy in cancer metabolic remodelling","volume":"98","author":"Ferro","year":"2020","journal-title":"Semin Cell Dev Biol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.3390\/cancers11091264","article-title":"Human cachexia induces changes in mitochondria, autophagy and apoptosis in the skeletal muscle","volume":"11","author":"de Castro","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B91","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3390\/cells11030426","article-title":"Autophagy contributes to metabolic reprogramming and therapeutic resistance in pancreatic tumors","volume":"11","author":"Reyes-Castellanos","year":"2022","journal-title":"Cells"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0367-9","article-title":"Protective autophagy elicited by Raf\u2192Mek\u2192Erk inhibition suggests a treatment strategy for Ras-driven cancers","volume":"25","author":"Kinsey","year":"2019","journal-title":"Nat Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13046-015-0221-y","article-title":"Metabolic reprogramming: The emerging concept and associated therapeutic strategies","volume":"34","author":"Yoshida","year":"2015","journal-title":"J Exp Clin Cancer Res"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.38","article-title":"Metabolism addiction in pancreatic cancer","volume":"5","author":"Blum","year":"2014","journal-title":"Cell Death Dis"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.25083","article-title":"Alterations in skeletal muscle oxidative phenotype in mice exposed to 3 weeks of normobaric hypoxia","volume":"231","author":"Slot","year":"2016","journal-title":"J Cell Physiol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111798","article-title":"Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more","volume":"141","author":"Hao","year":"2021","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3686","article-title":"Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development","volume":"20","author":"Mayers","year":"2014","journal-title":"Nat Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0350-z","article-title":"Branched-chain amino acids sustain pancreatic cancer growth by regulating lipid metabolism","volume":"51","author":"Lee","year":"2019","journal-title":"Exp Mol Med"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12621","article-title":"Brain metabolites in cholinergic and glutamatergic pathways are altered by pancreatic cancer cachexia","volume":"11","author":"Winnard","year":"2020","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-15-0671","article-title":"Pancreatic cancer metabolism: Breaking it down to build it back up","volume":"5","author":"Perera","year":"2015","journal-title":"Cancer Discovery"},{"key":"B101","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.plefa.2016.03.012","article-title":"Chronic pancreatitis and the composition of plasma phosphatidylcholine fatty acids","volume":"108","author":"Zeman","year":"2016","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2015.02.002","article-title":"Four types of fatty acids exert differential impact on pancreatic cancer growth","volume":"360","author":"Yu","year":"2015","journal-title":"Cancer Lett"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-13-0209","article-title":"Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer","volume":"19","author":"Zhang","year":"2013","journal-title":"Clin Cancer Res an Off J Am Assoc Cancer Res"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12307","article-title":"Three cachexia phenotypes and the impact of fat-only loss on survival in folfirinox therapy for pancreatic cancer","volume":"9","author":"Kays","year":"2018","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3390\/cells11050910","article-title":"Altered plasma fatty acid abundance is associated with cachexia in treatment-na\u00efve pancreatic cancer","volume":"11","author":"Gumpper-Fedus","year":"2022","journal-title":"Cells"},{"key":"B106","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.3390\/cancers12092477","article-title":"ATP production relies on fatty acid oxidation rather than glycolysis in pancreatic ductal adenocarcinoma","volume":"12","author":"Lee","year":"2020","journal-title":"Cancers"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1126\/science.1198973","article-title":"Adipose triglyceride lipase contributes to cancer-associated cachexia","volume":"333","author":"Das","year":"2011","journal-title":"Science"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.174","article-title":"Serum levels of IL-6 and IL-1\u03b2 can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer","volume":"108","author":"Mitsunaga","year":"2013","journal-title":"Br J Cancer"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3753","article-title":"Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis","volume":"49","author":"McDonald","year":"2017","journal-title":"Nat Genet"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-18-0567","article-title":"Acetyl-CoA metabolism supports multistep pancreatic tumorigenesis","volume":"9","author":"Carrer","year":"2019","journal-title":"Cancer Discovery"},{"key":"B111","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/msb.2011.56","article-title":"Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth","volume":"7","author":"Gaglio","year":"2011","journal-title":"Mol Syst Biol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"4945","DOI":"10.1038\/s41467-018-07472-8","article-title":"Oncogenic Kras supports pancreatic cancer through regulation of nucleotide synthesis","volume":"9","author":"Santana-Codina","year":"2018","journal-title":"Nat Commun"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1142\/s0192415x19500356","article-title":"\u0392-Pentagalloyl-Glucose sabotages pancreatic cancer cells and ameliorates cachexia in tumor-bearing mice","volume":"47","author":"Yang","year":"2019","journal-title":"Am J Chin Med"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.71","article-title":"From Krebs to clinic: Glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/nature19084","article-title":"Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion","volume":"536","author":"Sousa","year":"2016","journal-title":"Nature"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1549407","article-title":"Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis","volume":"21","author":"Ancrile","year":"2007","journal-title":"Genes Dev"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgp198","article-title":"ELR+ CXC chemokines and oncogenic Ras-mediated tumorigenesis","volume":"30","author":"O'Hayer","year":"2009","journal-title":"Carcinogenesis"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14437","article-title":"Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma","volume":"8","author":"Ju","year":"2017","journal-title":"Nat Commun"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1038\/nature14587","article-title":"Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism","volume":"524","author":"Perera","year":"2015","journal-title":"Nature"},{"key":"B120","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1136\/gutjnl-2018-317163","article-title":"Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer","volume":"69","author":"Liang","year":"2020","journal-title":"Gut"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2018.10.005","article-title":"Mutant p53 prevents gapdh nuclear translocation in pancreatic cancer cells favoring glycolysis and 2-deoxyglucose sensitivity","volume":"1865","author":"Butera","year":"2018","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.05.036","article-title":"TIGAR, a p53-inducible regulator of glycolysis and apoptosis","volume":"126","author":"Bensaad","year":"2006","journal-title":"Cell"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13593","article-title":"Human pancreatic cancer xenografts recapitulate key aspects of cancer cachexia","volume":"8","author":"Delitto","year":"2017","journal-title":"Oncotarget"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-15-1740","article-title":"Detection of pancreatic cancer-induced cachexia using a fluorescent myoblast reporter system and analysis of metabolite abundance","volume":"76","author":"Winnard","year":"2016","journal-title":"Cancer Res"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5843","article-title":"Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth","volume":"6","author":"Shukla","year":"2015","journal-title":"Oncotarget"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1186\/2049-3002-2-18","article-title":"Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia","volume":"2","author":"Shukla","year":"2014","journal-title":"Cancer Metab"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1002\/0471141755.ph1403s37","article-title":"Orthotopic model of human pancreatic ductal adenocarcinoma and cancer cachexia in nude mice","author":"Jones-Bolin","year":"2007","journal-title":"Curr Protoc Pharmacol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2014.10.037","article-title":"Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer","volume":"356","author":"Togashi","year":"2015","journal-title":"Cancer Lett"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132786","article-title":"TGF-\u03b2 blockade reduces mortality and metabolic changes in a validated murine model of pancreatic cancer cachexia","volume":"10","author":"Greco","year":"2015","journal-title":"PloS One"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.celrep.2019.07.016","article-title":"Modeling human cancer-induced cachexia","volume":"28","author":"Talbert","year":"2019","journal-title":"Cell Rep"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12550","article-title":"Distinct cachexia profiles in response to human pancreatic tumours in mouse limb and respiratory muscle","volume":"11","author":"Nosacka","year":"2020","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2015.01.016","article-title":"Patient-derived xenograft models for pancreatic adenocarcinoma demonstrate retention of tumor morphology through incorporation of murine stromal elements","volume":"185","author":"Delitto","year":"2015","journal-title":"Am J Pathol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i22.2867","article-title":"Intervention of mirtazapine on gemcitabine-induced mild cachexia in nude mice with pancreatic carcinoma xenografts","volume":"18","author":"Jiang","year":"2012","journal-title":"World J Gastroenterol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.canlet.2020.04.017","article-title":"Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia","volume":"484","author":"Shukla","year":"2020","journal-title":"Cancer Lett"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12225","article-title":"Establishment and characterization of a novel murine model of pancreatic cancer cachexia","volume":"8","author":"Michaelis","year":"2017","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.24580","article-title":"Pancreatic cancer-induced cachexia is Jak2-dependent in mice","volume":"229","author":"Gilabert","year":"2014","journal-title":"J Cell Physiol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1097\/mpa.0000000000001124","article-title":"Pancreatic cancer-induced cachexia and relevant mouse models","volume":"47","author":"Henderson","year":"2018","journal-title":"Pancreas"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1997.17","article-title":"Changes in nutritional status associated with unresectable pancreatic cancer","volume":"75","author":"Wigmore","year":"1997","journal-title":"Br J Cancer"},{"key":"B139","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4240\/wjgs.v10.i9.95","article-title":"Molecular therapeutic strategies targeting pancreatic cancer induced cachexia","volume":"10","author":"Yakovenko","year":"2018","journal-title":"World J Gastrointest Surg"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12377","article-title":"MyD88 signalling is critical in the development of pancreatic cancer cachexia","volume":"10","author":"Zhu","year":"2019","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1002\/cpph.80","article-title":"Preclinical models for studying the impact of macrophages on cancer cachexia","volume":"91","author":"Markov","year":"2020","journal-title":"Curr Protoc Pharmacol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M309789200","article-title":"Identification of an autoregulatory feedback pathway involving interleukin-1alpha in induction of constitutive NF-kappaB activation in pancreatic cancer cells","volume":"279","author":"Niu","year":"2004","journal-title":"J Biol Chem"},{"key":"B143","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1158\/2159-8290.Cd-18-0710","article-title":"IL1-induced JAK\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma","volume":"9","author":"Biffi","year":"2019","journal-title":"Cancer Discovery"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1593\/neo.11332","article-title":"Interleukin 1\u03b1 sustains the expression of inflammatory factors in human pancreatic cancer microenvironment by targeting cancer-associated fibroblasts","volume":"13","author":"Tjomsland","year":"2011","journal-title":"Neoplasia"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13212","article-title":"Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-1366","article-title":"Tumor-stroma IL1\u03b2-Irak4 feedforward circuitry drives tumor fibrosis, chemoresistance, and poor prognosis in pancreatic cancer","volume":"78","author":"Zhang","year":"2018","journal-title":"Cancer Res"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-016-3553-z","article-title":"A predictive model of inflammatory markers and patient-reported symptoms for cachexia in newly diagnosed pancreatic cancer patients","volume":"25","author":"Fogelman","year":"2017","journal-title":"Support Care Cancer"},{"key":"B148","article-title":"Association of IL-6 gene polymorphisms with cachexia susceptibility and survival time of patients with pancreatic cancer","volume":"38","author":"Zhang","year":"2008","journal-title":"Ann Clin Lab Sci"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/28.1.12","article-title":"Elevated serum interleukin-6 levels in patients with pancreatic cancer","volume":"28","author":"Okada","year":"1998","journal-title":"Jpn J Clin Oncol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20672","article-title":"Cytokines in pancreatic carcinoma: Correlation with phenotypic characteristics and prognosis","volume":"101","author":"Ebrahimi","year":"2004","journal-title":"Cancer"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/s1499-3872(14)60259-9","article-title":"Interleukin-6: A villain in the drama of pancreatic cancer development and progression","volume":"13","author":"Holmer","year":"2014","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2018.11.002","article-title":"Circulating interleukin-6 is associated with disease progression, but not cachexia in pancreatic cancer","volume":"19","author":"Ramsey","year":"2019","journal-title":"Pancreatology"},{"key":"B153","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/jcp.26811","article-title":"Adipose tissue dysfunction in cancer cachexia","volume":"234","author":"Daas","year":"2018","journal-title":"J Cell Physiol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12627","article-title":"Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer-induced cachexia","volume":"11","author":"Vaes","year":"2020","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B155","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.3390\/cancers11121863","article-title":"IL-8 released from human pancreatic cancer and tumor-associated stromal cells signals through a CXCR2-ERK1\/2 axis to induce muscle atrophy","volume":"11","author":"Callaway","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B156","article-title":"Serum levels of tumor necrosis factor-alpha and nutritional status in pancreatic cancer patients","volume":"21","author":"Karayiannakis","year":"2001","journal-title":"Anticancer Res"},{"key":"B157","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1053\/j.gastro.2022.02.017","article-title":"Circular RNA ANAPC7 inhibits tumor growth and muscle wasting Via PHLPP2-AKT-TGF-\u03b2 signaling axis in pancreatic cancer","volume":"162","author":"Shi","year":"2022","journal-title":"Gastroenterology"},{"key":"B158","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/ijc.2910490115","article-title":"Severe cachexia in mice inoculated with interferon-Gamma-Producing tumor cells","volume":"49","author":"Matthys","year":"1991","journal-title":"Int J Cancer"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2019.01.015","article-title":"Plasma IFN-\u03b3-Inducible chemokines CXCL9 and CXCL10 correlate with survival and chemotherapeutic efficacy in advanced pancreatic ductal adenocarcinoma","volume":"19","author":"Qian","year":"2019","journal-title":"Pancreatology"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12010003","article-title":"Upregulation of ZIP14 and altered zinc homeostasis in muscles in pancreatic cancer cachexia","volume":"12","author":"Shakri","year":"2019","journal-title":"Cancers"},{"key":"B161","doi-asserted-by":"publisher","first-page":"7986","DOI":"10.1038\/s41598-021-87213-y","article-title":"Role of stromal activin a in human pancreatic cancer and metastasis in mice","volume":"11","author":"Mancinelli","year":"2021","journal-title":"Sci Rep"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12461","article-title":"The systemic activin response to pancreatic cancer: Implications for effective cancer cachexia therapy","volume":"10","author":"Zhong","year":"2019","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12998","article-title":"Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: Role of activin","volume":"13","author":"Zhong","year":"2022","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2014.06.011","article-title":"A switch from white to brown fat increases energy expenditure in cancer-associated cachexia","volume":"20","author":"Petruzzelli","year":"2014","journal-title":"Cell Metab"},{"key":"B165","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.3390\/cancers14081948","article-title":"Evaluation of browning markers in subcutaneous adipose tissue of newly diagnosed gastrointestinal cancer patients with and without cachexia","volume":"14","author":"Molfino","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2001.1992","article-title":"Modulation of adipocyte G-protein expression in cancer cachexia by a lipid-mobilizing factor (LMF)","volume":"85","author":"Islam-Ali","year":"2001","journal-title":"Br J Cancer"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100121RRR","article-title":"Caveolin-1 increases glycolysis in pancreatic cancer cells and triggers cachectic states","volume":"35","author":"Hu","year":"2021","journal-title":"FASEB J"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2001.02583.x","article-title":"Ligation of the Fas antigen stimulates chemokine secretion in pancreatic cancer cell line PANC-1","volume":"16","author":"Shimada","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"B169","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41467-017-00726-x","article-title":"Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat Commun"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.4161\/cc.24488","article-title":"Induction of trif- or MyD88-dependent pathways perturbs cell cycle regulation in pancreatic cancer","volume":"12","author":"Zambirinis","year":"2013","journal-title":"Cell Cycle"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1101\/gad.348523.121","article-title":"The biological underpinnings of therapeutic resistance in pancreatic cancer","volume":"35","author":"Beatty","year":"2021","journal-title":"Genes Dev"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12939","article-title":"Hypothalamic\u2013Pituitary\u2013Adrenal axis activation and glucocorticoid-responsive gene expression in skeletal muscle and liver of apc mice","volume":"13","author":"Martin","year":"2022","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3785","article-title":"Serum pthrp predicts weight loss in cancer patients independent of hypercalcemia, inflammation, and tumor burden","volume":"101","author":"Hong","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia","volume":"303","author":"Bonetto","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v9.i7.1567","article-title":"Role of NF-kappaB and cytokine in experimental cancer cachexia","volume":"9","author":"Zhou","year":"2003","journal-title":"World J Gastroenterol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19123836","article-title":"Local and systemic cytokine profiling for pancreatic ductal adenocarcinoma to study cancer cachexia in an era of precision medicine","volume":"19","author":"Gerber","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-07-5704","article-title":"Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis","volume":"68","author":"Egberts","year":"2008","journal-title":"Cancer Res"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-010-1297-5","article-title":"Intra-abdominal fat predicts survival in pancreatic cancer","volume":"14","author":"Balentine","year":"2010","journal-title":"J gastrointestinal Surg Off J Soc Surg Alimentary Tract"},{"key":"B179","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1038\/s41598-017-02088-2","article-title":"Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling","volume":"7","author":"Pettersen","year":"2017","journal-title":"Sci Rep"},{"key":"B180","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12944-018-0657-0","article-title":"Interleukin-6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and browning","volume":"17","author":"Han","year":"2018","journal-title":"Lipids Health Dis"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1002\/rco2.24","article-title":"Jak inhibitors suppress cancer cachexia-associated anorexia and adipose wasting in mice","volume":"3","author":"Arora","year":"2020","journal-title":"JCSM Rapid Commun"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22394","article-title":"Expression profiling identifies MicroRNA signature in pancreatic cancer","volume":"120","author":"Lee","year":"2007","journal-title":"Int J Cancer"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1402714111","article-title":"Microvesicles containing miRNAs promote muscle cell death in cancer cachexia Via TLR7","volume":"111","author":"He","year":"2014","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B184","first-page":"28","article-title":"Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer","volume":"3","author":"Ali","year":"2010","journal-title":"Am J Transl Res"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-017-0087-6","article-title":"Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers","volume":"5","author":"Calatayud","year":"2017","journal-title":"biomark Res"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2009.137364","article-title":"MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions","volume":"56","author":"du Rieu","year":"2010","journal-title":"Clin Chem"},{"key":"B187","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.arcmed.2011.01.006","article-title":"Bcl-2 upregulation induced by miR21 Via a direct interaction is associated with apoptosis and chemoresistance in MIA PaCa-2 pancreatic cancer cells","volume":"42","author":"Dong","year":"2011","journal-title":"Arch Med Res"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e3181ba82e1","article-title":"Antisense inhibition of MicroRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma","volume":"38","author":"Park","year":"2009","journal-title":"Pancreas"},{"key":"B189","article-title":"Chemosensitivity induced by down-regulation of MicroRNA-21 in gemcitabine-resistant pancreatic cancer cells by indole-3-Carbinol","volume":"33","author":"Paik","year":"2013","journal-title":"Anticancer Res"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2012.10.011","article-title":"The serum miR21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR21 expression confers chemoresistance by targeting FasL","volume":"7","author":"Wang","year":"2013","journal-title":"Mol Oncol"},{"key":"B191","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/onc.2008.370","article-title":"An autoregulatory loop mediated by miR21 and PDCD4 controls the AP-1 activity in ras transformation","volume":"28","author":"Talotta","year":"2009","journal-title":"Oncogene"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-11-0031","article-title":"PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-\u03baB-Cytokine network","volume":"1","author":"Ying","year":"2011","journal-title":"Cancer Discovery"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-09-4467","article-title":"MicroRNA-21 in pancreatic cancer: Correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity","volume":"70","author":"Giovannetti","year":"2010","journal-title":"Cancer Res"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.2147\/ott.s211535","article-title":"Downregulation of miR21 inhibits the malignant phenotype of pancreatic cancer cells by targeting vhl","volume":"12","author":"Sun","year":"2019","journal-title":"OncoTargets Ther"},{"key":"B195","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3390\/ijms23031275","article-title":"MicroRNA-21 regulates stemness in pancreatic ductal adenocarcinoma cells","volume":"23","author":"Mortoglou","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1209414109","article-title":"MicroRNAs bind to toll-like receptors to induce prometastatic inflammatory response","volume":"109","author":"Fabbri","year":"2012","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9040345","article-title":"Inflamma-miR21 negatively regulates myogenesis during ageing","volume":"9","author":"Borja-Gonzalez","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"B198","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/jhg.2016.59","article-title":"MicroRNA in pancreatic cancer","volume":"62","author":"Yonemori","year":"2017","journal-title":"J Hum Genet"},{"key":"B199","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41580-018-0045-7","article-title":"Regulation of MicroRNA function in animals","volume":"20","author":"Gebert","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.783231","article-title":"Impact of TNF-\u03b1 gene polymorphisms on pancreatic and non-small cell lung cancer-induced cachexia in adult Egyptian patients: A focus on pathogenic trajectories","volume":"11","author":"Yehia","year":"2021","journal-title":"Front Oncol"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0703942104","article-title":"Tumor protein 53-induced nuclear protein 1 expression is repressed by miR155, and its restoration inhibits pancreatic tumor development","volume":"104","author":"Gironella","year":"2007","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.04.057","article-title":"A MicroRNA signature identifies pancreatic ductal adenocarcinoma patients at risk for lymph node metastases","volume":"159","author":"Nishiwada","year":"2020","journal-title":"Gastroenterology"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.3892\/or.2013.2576","article-title":"Regulation of miR155 affects pancreatic cancer cell invasiveness and migration by modulating the STAT3 signaling pathway through SOCS1","volume":"30","author":"Huang","year":"2013","journal-title":"Oncol Rep"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12747","article-title":"Pancreatic cancer-secreted miR155 implicates in the conversion from normal fibroblasts to cancer-associated fibroblasts","volume":"106","author":"Pang","year":"2015","journal-title":"Cancer Sci"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1177\/1947601911409212","article-title":"MicroRNA-375 and MicroRNA-221: Potential noncoding RNAs associated with antiproliferative activity of benzyl isothiocyanate in pancreatic cancer","volume":"2","author":"Basu","year":"2011","journal-title":"Genes Cancer"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071309","article-title":"MicroRNA-221 mediates the effects of PDGF-BB on migration, proliferation, and the epithelial-mesenchymal transition in pancreatic cancer cells","volume":"8","author":"Su","year":"2013","journal-title":"PloS One"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3686","article-title":"miR221\/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases","volume":"6","author":"Xu","year":"2015","journal-title":"Oncotarget"},{"key":"B208","article-title":"Down-regulation of miR221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, P27(Kip1), P57(Kip2), and  PUMA","volume":"3","author":"Sarkar","year":"2013","journal-title":"Am J Cancer Res"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2014.06.011","article-title":"Small molecule inhibitor of myogenic MicroRNAs leads to a discovery of miR221\/222-myoD-myomiRs regulatory pathway","volume":"21","author":"Tan","year":"2014","journal-title":"Chem Biol"},{"key":"B210","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.canlet.2014.01.020","article-title":"MicroRNA let-7 downregulates STAT3 phosphorylation in pancreatic cancer cells by increasing SOCS3 expression","volume":"347","author":"Patel","year":"2014","journal-title":"Cancer Lett"},{"key":"B211","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ajpath.2018.10.005","article-title":"miRNA and gene expression in pancreatic ductal adenocarcinoma","volume":"189","author":"Tesfaye","year":"2019","journal-title":"Am J Pathol"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032068","article-title":"MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors","volume":"7","author":"Jiao","year":"2012","journal-title":"PloS One"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12168","article-title":"Small rnaome profiling from human skeletal muscle: Novel miRNAs and their targets associated with cancer cachexia","volume":"8","author":"Narasimhan","year":"2017","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20081962","article-title":"The pathway to cancer cachexia: MicroRNA-regulated networks in muscle wasting based on integrative meta-analysis","volume":"20","author":"Freire","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12384","article-title":"MicroRNAs in muscle wasting","volume":"9","author":"Suzuki","year":"2018","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.561845","article-title":"Involvement of MicroRNAs in the regulation of muscle wasting during catabolic conditions","volume":"289","author":"Soares","year":"2014","journal-title":"J Biol Chem"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/367561","article-title":"Cancer cachexia and MicroRNAs","volume":"2015","author":"Camargo","year":"2015","journal-title":"Mediators Inflammation"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101101","article-title":"Non-coding RNAs in cancer-associated cachexia: Clinical implications and future perspectives","volume":"14","author":"Kottorou","year":"2021","journal-title":"Trans Oncol"},{"key":"B219","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3892\/etm.2022.11373","article-title":"MicroRNAs: Novel players in the diagnosis and treatment of cancer cachexia (Review)","volume":"24","author":"Li","year":"2022","journal-title":"Exp Ther Med"},{"key":"B220","doi-asserted-by":"publisher","first-page":"59","DOI":"10.21037\/apm.2018.08.05","article-title":"Combination therapy in cachexia","volume":"8","author":"Del Fabbro","year":"2019","journal-title":"Ann Palliat Med"},{"key":"B221","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/intimm\/dxu102","article-title":"Anti-TNF therapy: Past, present and future","volume":"27","author":"Monaco","year":"2014","journal-title":"Int Immunol"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.2010.28608E","article-title":"Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting","volume":"91","author":"Gullett","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"B223","article-title":"The effect of blocking TNF-alpha in patients with cancer-related cachexia and anorexia","volume":"149","author":"Gueta","year":"2010","journal-title":"Harefuah"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e318279b87f","article-title":"Disrupting cytokine signaling in pancreatic cancer: A phase I\/II study of etanercept in combination with gemcitabine in patients with advanced disease","volume":"42","author":"Wu","year":"2013","journal-title":"Pancreas"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2009.06.020","article-title":"A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and\/or poor performance non-small cell lung cancer patients (N01C9)","volume":"68","author":"Jatoi","year":"2010","journal-title":"Lung Cancer"},{"key":"B226","first-page":"18","article-title":"A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia","volume":"6","author":"Wiedenmann","year":"2008","journal-title":"J Support Oncol"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12331","article-title":"Ly2495655, an antimyostatin antibody, in pancreatic cancer: A randomized, phase 2 trial","volume":"9","author":"Golan","year":"2018","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B228","doi-asserted-by":"publisher","first-page":"62","DOI":"10.14283\/jfa.2016.81","article-title":"A phase 2 randomized study investigating the efficacy and safety of myostatin antibody Ly2495655 versus placebo in patients undergoing elective total hip arthroplasty","volume":"5","author":"Woodhouse","year":"2016","journal-title":"J Frailty Aging"},{"key":"B229","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.jpainsymman.2013.01.009","article-title":"Favorable responses to tocilizumab in two patients with cancer-related cachexia","volume":"46","author":"Hirata","year":"2013","journal-title":"J Pain Symptom Manage"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102436","article-title":"Tocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancer","volume":"9","author":"Ando","year":"2014","journal-title":"PloS One"},{"key":"B231","doi-asserted-by":"publisher","first-page":"67","DOI":"10.21037\/apm.2018.07.06","article-title":"Anti-cytokines in the treatment of cancer cachexia","volume":"8","author":"Prado","year":"2019","journal-title":"Ann Palliat Med"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2015.61.4578","article-title":"Randomized, double-blind, phase II study of ruxolitinib or placebo in combination with capecitabine in patients with metastatic pancreatic cancer for whom therapy with gemcitabine has failed","volume":"33","author":"Hurwitz","year":"2015","journal-title":"J Clin Oncol"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-018-0580-2","article-title":"Ruxolitinib + capecitabine in Advanced\/Metastatic pancreatic cancer after disease Progression\/Intolerance to first-line therapy: Janus 1 and 2 randomized phase III studies","volume":"36","author":"Hurwitz","year":"2018","journal-title":"Invest New Drugs"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2011.01917.x","article-title":"Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer","volume":"102","author":"Schlingensiepen","year":"2011","journal-title":"Cancer Sci"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noq142","article-title":"Targeted therapy for high-grade glioma with the TGF-\u03b22 inhibitor trabedersen: Results of a randomized and controlled phase IIb study","volume":"13","author":"Bogdahn","year":"2011","journal-title":"Neuro Oncol"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1038\/nm1677","article-title":"Tumor-induced anorexia and weight loss are mediated by the TGF-\u03b2 superfamily cytokine MIC-1","volume":"13","author":"Johnen","year":"2007","journal-title":"Nat Med"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12205","article-title":"Effect of bimagrumab on thigh muscle volume and composition in men with casting-induced atrophy","volume":"8","author":"Rooks","year":"2017","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12639","article-title":"Safety and pharmacokinetics of bimagrumab in healthy older and obese adults with body composition changes in the older cohort","volume":"11","author":"Rooks","year":"2020","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32406","article-title":"A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia","volume":"125","author":"Hamauchi","year":"2019","journal-title":"Cancer"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12675","article-title":"The regulatory approval of anamorelin for treatment of cachexia in patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: Facts and numbers","volume":"12","author":"Wakabayashi","year":"2021","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31128","article-title":"Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (Ono-7643-04)","volume":"124","author":"Katakami","year":"2018","journal-title":"Cancer"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-012-1500-1","article-title":"Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: A multicenter, randomized, double-blind, crossover, pilot study","volume":"21","author":"Garcia","year":"2013","journal-title":"Support Care Cancer"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-Small-Cell lung cancer and cachexia (Romana 1 and romana 2): Results from two randomised, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet Oncol"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12851","article-title":"Ameliorating cancer cachexia by inhibiting cancer cell release of Hsp70 and Hsp90 with omeprazole","volume":"13","author":"Liu","year":"2022","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2014.951731","article-title":"Ms-20, a chemotherapeutical adjuvant, reduces chemo-associated fatigue and appetite loss in cancer patients","volume":"66","author":"Chi","year":"2014","journal-title":"Nutr Cancer"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12126","article-title":"Espindolol for the treatment and prevention of cachexia in patients with stage III\/IV non-small cell lung cancer or colorectal cancer: A randomized, double-blind, placebo-controlled, international multicentre phase II study (the act-one trial)","volume":"7","author":"Stewart Coats","year":"2016","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-17-3878","article-title":"The TLR7\/8\/9 antagonist IMO-8503 inhibits cancer-induced cachexia","volume":"78","author":"Calore","year":"2018","journal-title":"Cancer Res"},{"key":"B248","doi-asserted-by":"publisher","first-page":"4682","DOI":"10.1038\/s41467-019-12657-w","article-title":"The TLR7\/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer","volume":"10","author":"Michaelis","year":"2019","journal-title":"Nat Commun"},{"key":"B249","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0304-3835(95)04026-9","article-title":"Muscle hypercatabolism during cancer cachexia is not reversed by the glucocorticoid receptor antagonist Ru38486","volume":"99","author":"Llovera","year":"1996","journal-title":"Cancer Lett"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1207\/s15327914nc352_16","article-title":"Glucocorticoid blockade does not abrogate tumor-induced cachexia","volume":"35","author":"Rivadeneira","year":"1999","journal-title":"Nutr Cancer"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9610(02)00823-1","article-title":"Reversal of cancer-related wasting using oral supplementation with a combination of beta-Hydroxy-Beta-Methylbutyrate, arginine, and glutamine","volume":"183","author":"May","year":"2002","journal-title":"Am J Surg"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-008-0403-7","article-title":"A randomized, double-blind, placebo-controlled trial of a beta-hydroxyl beta-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122)","volume":"16","author":"Berk","year":"2008","journal-title":"Support Care Cancer"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.2174\/1381612826666200218100420","article-title":"Dietary amino acids and immunonutrition supplementation in cancer-induced skeletal muscle mass depletion: A mini-review","volume":"26","author":"Soares","year":"2020","journal-title":"Curr Pharm Des"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1988.tb01282.x","article-title":"Skeletal muscle and whole body protein turnover in cardiac cachexia: Influence of branched-chain amino acid administration","volume":"18","author":"Morrison","year":"1988","journal-title":"Eur J Clin Invest"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1097\/01.mco.0000172581.79266.19","article-title":"Branched-chain amino acids: The best compromise to achieve anabolism","volume":"8","author":"Laviano","year":"2005","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19860701)58:1<147::aid-cncr2820580126>3.0.co;2-i","article-title":"Improved protein kinetics and albumin synthesis by branched chain amino acid-enriched total parenteral nutrition in cancer cachexia. a prospective randomized crossover trial","volume":"58","author":"Tayek","year":"1986","journal-title":"Cancer"},{"key":"B257","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.3390\/nu14112344","article-title":"Randomized clinical trial: Effects of \u0392-Hydroxy-\u0392-Methylbutyrate (Hmb)-enriched vs. hmb-free oral nutritional supplementation in malnourished cirrhotic patients","volume":"14","author":"Espina","year":"2022","journal-title":"Nutrients"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12201","article-title":"A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer","volume":"8","author":"Solheim","year":"2017","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B259","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.3390\/cancers13061206","article-title":"N-3 long-chain polyunsaturated fatty acids, eicosapentaenoic and docosahexaenoic acid, and the role of supplementation during cancer treatment: A scoping review of current clinical evidence","volume":"13","author":"Newell","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.1079\/nrr200488","article-title":"N-3 polyunsaturated fatty acids throughout the cancer trajectory: Influence on disease incidence, progression, response to therapy and cancer-associated cachexia","volume":"17","author":"Baracos","year":"2004","journal-title":"Nutr Res Rev"},{"key":"B261","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12944-017-0495-5","article-title":"Dietary supplementation with n-3-Fatty acids in patients with pancreatic cancer and cachexia: Marine phospholipids versus fish oil - a randomized controlled double-blind trial","volume":"16","author":"Werner","year":"2017","journal-title":"Lipids Health Dis"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnesp.2019.12.004","article-title":"Fish oil supplementation in cancer patients. capsules or nutritional drink supplements? a controlled study of compliance","volume":"35","author":"Schmidt","year":"2020","journal-title":"Clin Nutr ESPEN"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.2174\/0929867324666170616111225","article-title":"The complexity of omega-3 fatty acid modulation of signaling pathways related to pancreatic cancer","volume":"25","author":"Torres","year":"2018","journal-title":"Curr Med Chem"},{"key":"B264","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-015-9572-2","article-title":"Omega-3 polyunsaturated fatty acids and cancer: Lessons learned from clinical trials","volume":"34","author":"Nabavi","year":"2015","journal-title":"Cancer Metastasis Rev"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2018.12.001","article-title":"New insights on the regulation of cancer cachexia by n-3 polyunsaturated fatty acids","volume":"196","author":"Gorjao","year":"2019","journal-title":"Pharmacol Ther"},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2014-000694","article-title":"Pancreatic enzyme replacement therapy (Pert) for malabsorption in patients with metastatic pancreatic cancer","volume":"6","author":"Landers","year":"2016","journal-title":"BMJ Support Palliat Care"},{"key":"B267","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.cgh.2019.08.061","article-title":"Effects of pancreatic enzyme replacement therapy on body weight and nutritional assessments after pancreatoduodenectomy in a randomized trial","volume":"18","author":"Kim","year":"2020","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.1057930\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T06:22:46Z","timestamp":1668666166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.1057930\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,17]]},"references-count":267,"alternative-id":["10.3389\/fonc.2022.1057930"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.1057930","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,17]]},"article-number":"1057930"}}